The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced renal cell carcinoma (RCC): Updated analysis of KEYNOTE-426.
 
Elizabeth R. Plimack
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Flatiron Health; Genentech/Roche; Incyte; Janssen; Merck; Pfizer; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Brian I. Rini
Leadership - MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Merck; Peloton Therapeutics; Pfizer; Roche/Genentech; Surface Oncology; synthorx
Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer
 
Viktor Stus
Speakers' Bureau - Astellas Pharma
Research Funding - Astellas Pharma; Merck
Travel, Accommodations, Expenses - Bionorica
 
Rustem Gafanov
No Relationships to Disclose
 
Tom Waddell
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen
 
Dmitry Nosov
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Sanofi
Travel, Accommodations, Expenses - Bayer
 
Frédéric Pouliot
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen; Progenics; Sanofi
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Sanofi
Research Funding - Astellas Pharma; Bayer; Sanofi
Expert Testimony - Amgen; Astellas Pharma; Bayer; Sanofi
Travel, Accommodations, Expenses - Bayer; Sanofi
 
Denis Soulieres
Honoraria - Adlai Nortye; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Bohuslav Melichar
Honoraria - Amgen; Amgen; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eliamm; Eliamm; Janssen; Janssen; Merck Serono; Merck Serono; MSD; MSD; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche; Sanofi; Sanofi; SERVIER; SERVIER
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eliamm; Eliamm; Janssen; Janssen; Merck Serono; Merck Serono; MSD; MSD; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche; Sanofi; Sanofi; SERVIER; SERVIER
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck
Other Relationship - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; SERVIER
 
Ihor Vynnychenko
No Relationships to Disclose
 
Sergio Jobim Azevedo
No Relationships to Disclose
 
Delphine Borchiellini
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Exelixis; Infinity Pharmaceuticals; Janssen; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen; Pfizer; Roche
 
Raymond S. McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche
 
Jens Bedke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Nektar; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Satoshi Tamada
No Relationships to Disclose
 
Lina Yin
Employment - Merck
 
Mei Chen
Employment - Merck
Stock and Other Ownership Interests - GlaxoSmithKline; Merck
 
L. Rhoda Molife
Employment - Merck
Stock and Other Ownership Interests - MSD
 
Michael B. Atkins
Honoraria - Merck
Consulting or Advisory Role - Agenus; Array BioPharma; Arrowhead Pharmaceuticals; Aveo; Bristol-Myers Squibb; Cota Healthcare; Eisai; Exelixis; Fathom Biotechnology; Genentech; Glactone Pharma; Immunocore; Iovance Biotherapeutics; Leads Biolabs; Merck; Neoleukin Therapeutics; Novartis; Oncolys BioPharma; Pfizer; Pneuma Respiratory; Pyxis; Surface Oncology; Werewolf Pharma; X4 Pharma
Research Funding - Bristol-Myers Squibb (Inst)
 
Thomas Powles
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ferring; Gerson Lehrman Group; Janssen Research & Development; MERCK; Novartis; Pfizer; Roche/Genentech; Seattle Genetics/Astellas
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Incyte; Ipsen; Merck; Novartis; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ferring; MSD; Novartis/Ipsen; Pfizer; Research to Practice; Roche/Genentech